But Dr. Joseph McGowan, HIV services medical director at Northwell Health ... which tests people like those seeking treatment ...
The treatment worked so well that her tumor shrank by more than ... and in four the volume of tumors were reduced by at least ...
Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...
From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...
Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...
Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...
A new proven protocol in which doxycycline is used to prevent sexually transmitted infections, called doxyPEP, has been an ...
The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic ...
Sure, condoms are still an effective strategy for lowering the risk of sexually transmitted infections (STIs) — but now, they ...
Recent health data reveals an alarming rise in HIV transmission rate between older men and young women, presenting a complex ...
Overall, the HIV treatment market continues to grow in line with our expectations ... We'll be sharing updated data at the ASH conference and look forward to potentially offering Anito-cel’s ...
As part of our coverage of the biennial AIDS conference from the International AIDS Society, we spoke with Madalitso Juwayeyi, program manager at FACT-Malawi, to learn more about her organization and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback